HU165181B - - Google Patents

Info

Publication number
HU165181B
HU165181B HUCI1185A HUCI001185A HU165181B HU 165181 B HU165181 B HU 165181B HU CI1185 A HUCI1185 A HU CI1185A HU CI001185 A HUCI001185 A HU CI001185A HU 165181 B HU165181 B HU 165181B
Authority
HU
Hungary
Application number
HUCI1185A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HUCI1185A priority Critical patent/HU165181B/hu
Priority to DE2252665A priority patent/DE2252665A1/de
Priority to IL40685A priority patent/IL40685A/en
Priority to AT925372A priority patent/AT332531B/de
Priority to GB5049572A priority patent/GB1403900A/en
Priority to DD166641A priority patent/DD100631A1/xx
Priority to SU721846969A priority patent/SU1009467A1/ru
Priority to CA155,789A priority patent/CA978479A/en
Priority to CS727556A priority patent/CS217603B1/cs
Publication of HU165181B publication Critical patent/HU165181B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUCI1185A 1971-11-08 1971-11-08 HU165181B (enrdf_load_stackoverflow)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (enrdf_load_stackoverflow) 1971-11-08 1971-11-08
DE2252665A DE2252665A1 (de) 1971-11-08 1972-10-27 Nierensteinloesendes praeparat und verfahren zu dessen herstellung
IL40685A IL40685A (en) 1971-11-08 1972-10-27 Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation
AT925372A AT332531B (de) 1971-11-08 1972-10-31 Verfahren zur herstellung eines nierensteinlosenden praparates
GB5049572A GB1403900A (en) 1971-11-08 1972-11-02 Pharmaceutical composition
DD166641A DD100631A1 (enrdf_load_stackoverflow) 1971-11-08 1972-11-02
SU721846969A SU1009467A1 (ru) 1971-11-08 1972-11-04 Средство дл растворени мочевых конкрементов
CA155,789A CA978479A (en) 1971-11-08 1972-11-07 Composition for the dissolution of renal calculi and process for the preparation thereof
CS727556A CS217603B1 (en) 1971-11-08 1972-11-08 Method of preparing compositions for dissolving renal calculi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (enrdf_load_stackoverflow) 1971-11-08 1971-11-08

Publications (1)

Publication Number Publication Date
HU165181B true HU165181B (enrdf_load_stackoverflow) 1974-07-27

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
HUCI1185A HU165181B (enrdf_load_stackoverflow) 1971-11-08 1971-11-08

Country Status (9)

Country Link
AT (1) AT332531B (enrdf_load_stackoverflow)
CA (1) CA978479A (enrdf_load_stackoverflow)
CS (1) CS217603B1 (enrdf_load_stackoverflow)
DD (1) DD100631A1 (enrdf_load_stackoverflow)
DE (1) DE2252665A1 (enrdf_load_stackoverflow)
GB (1) GB1403900A (enrdf_load_stackoverflow)
HU (1) HU165181B (enrdf_load_stackoverflow)
IL (1) IL40685A (enrdf_load_stackoverflow)
SU (1) SU1009467A1 (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826642C2 (de) 1978-06-19 1987-04-23 Dr. Madaus & Co, 5000 Köln Orales Urolithiasismittel
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー，インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
US8603989B2 (en) 2008-05-22 2013-12-10 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
FR2967576B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
CA2906907C (en) * 2013-03-15 2021-04-13 New York University Citrate containing beverage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
AT332531B (de) 1976-10-11
CA978479A (en) 1975-11-25
CS217603B1 (en) 1983-01-28
SU1009467A1 (ru) 1983-04-07
IL40685A (en) 1976-08-31
DE2252665C2 (enrdf_load_stackoverflow) 1987-09-10
DD100631A1 (enrdf_load_stackoverflow) 1973-10-05
GB1403900A (en) 1975-08-28
IL40685A0 (en) 1972-12-29
DE2252665A1 (de) 1973-05-10
ATA925372A (de) 1976-01-15

Similar Documents

Publication Publication Date Title
ATA136472A (enrdf_load_stackoverflow)
HU165181B (enrdf_load_stackoverflow)
AU459467B2 (enrdf_load_stackoverflow)
AU2658571A (enrdf_load_stackoverflow)
AU2691671A (enrdf_load_stackoverflow)
AU2726271A (enrdf_load_stackoverflow)
AU3005371A (enrdf_load_stackoverflow)
AU2742671A (enrdf_load_stackoverflow)
AU2941471A (enrdf_load_stackoverflow)
AU2564071A (enrdf_load_stackoverflow)
AU2684071A (enrdf_load_stackoverflow)
AU2485671A (enrdf_load_stackoverflow)
AU2952271A (enrdf_load_stackoverflow)
AU2503871A (enrdf_load_stackoverflow)
AU2706571A (enrdf_load_stackoverflow)
AU2654071A (enrdf_load_stackoverflow)
AU2588771A (enrdf_load_stackoverflow)
AU2740271A (enrdf_load_stackoverflow)
AU2577671A (enrdf_load_stackoverflow)
AU2940971A (enrdf_load_stackoverflow)
AU2963771A (enrdf_load_stackoverflow)
AR202997Q (enrdf_load_stackoverflow)
AU1109576A (enrdf_load_stackoverflow)
AU2724971A (enrdf_load_stackoverflow)
AU2455871A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628